GoldenGolden
Globavir Biosciences

Globavir Biosciences

A biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease.

All edits

Edits on 11 May, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 11 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Venture round
Edits on 28 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+2 properties)
Infobox
Investors
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
September 20, 2016
Edits on 21 Aug, 2020
Lax Mariappan
Lax Mariappan edited on 21 Aug, 2020
Edits made to:
Infobox (+3 properties)
Edits on 14 Jul, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 14 Jul, 2020
Edits made to:
Article (+6/-6 characters)
Article

On January 21, 2015 Globavir Biosciences announced raising $4 million in venture funding from StartXStartX, Stanford University Venture Fund, and Sorrento Therapeutics.

Edits on 3 Jul, 2020
Jason D. Rowley
Jason D. Rowley approved a suggestion from Golden's AI on 3 Jul, 2020
Edits made to:
Article (+21/-21 characters)
Article

On January 21, 2015 Globavir Biosciences announced raising $4 million in venture funding from StartX, Stanford University Venture Fund, and Sorrento TherapeuticsSorrento Therapeutics.

Edits on 26 Jun, 2020
Jeremiah England
Jeremiah England approved a suggestion from Golden's AI on 26 Jun, 2020
Edits made to:
Article (+11/-11 characters)
Article

Globavir Biosciences is a biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease that is headquartered in Los Altos, California and was founded in 2011 by Shalabh Gupta and Vijay Pande. The company is focused on commercializing re-purposed drugs for controlling infectious diseases such as coronavirus, dengue fever, ebola, and ChikungunyaChikungunya. Their lead drug candidate is called GBV-006 and is a combination of two drugs approved by the FDA for affecting viral load and mortality of viral infections.

Jeremiah England
Jeremiah England approved a suggestion from Golden's AI on 26 Jun, 2020
Edits made to:
Article (+21/-21 characters)
Article

Globavir Biosciences is a biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease that is headquartered in Los Altos, CaliforniaLos Altos, California and was founded in 2011 by Shalabh Gupta and Vijay Pande. The company is focused on commercializing re-purposed drugs for controlling infectious diseases such as coronavirus, dengue fever, ebola, and Chikungunya. Their lead drug candidate is called GBV-006 and is a combination of two drugs approved by the FDA for affecting viral load and mortality of viral infections.

Edits on 25 Jun, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
6,000,000
Total funding amount (USD)
7,500,000
Golden AI
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1 properties)
Golden AI"Funding autocalculation"
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
2,000,000
Total funding amount (USD)
6,000,000
Golden AI
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1 properties)
Golden AI"Funding autocalculation"
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
2,000,000
Golden AI
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1 properties)
Dawson Sewell
Dawson Sewell edited on 25 Jun, 2020
Edits made to:
Infobox (+8 properties)
Timeline (+1 events) (+299 characters)
Description (+109 characters)
Article (+1273 characters)
Topic thumbnail

Globavir Biosciences

A biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease.

Article

Globavir Biosciences is a biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease that is headquartered in Los Altos, California and was founded in 2011 by Shalabh Gupta and Vijay Pande. The company is focused on commercializing re-purposed drugs for controlling infectious diseases such as coronavirus, dengue fever, ebola, and Chikungunya. Their lead drug candidate is called GBV-006 and is a combination of two drugs approved by the FDA for affecting viral load and mortality of viral infections.

Partnerships
Bio-Rad Laboratories

On October 17, 2016 Globavir Biosciences announced entering a partnership with Bio-Rad Laboratories to licence Globavir's PanGlob Dengue detection technology. There were no financial details of the partnership and licensing agreement between the two companies.

Funding
Seed

On November 12, 2012 Globavir Biosciences announced raising $2 million in seed funding from undisclosed investors.

Venture

On January 21, 2015 Globavir Biosciences announced raising $4 million in venture funding from StartX, Stanford University Venture Fund, and Sorrento Therapeutics.

Venture

On September 20, 2016 Globavir Biosciences announced raising $1.5 million in venture funding from undisclosed investors.

Infobox
Email address
info@globavir.com
Founded date
2011
Full address
5150 EL CAMINO REAL, Los Altos, California 94022, US
Phone number
+116503514495
Timeline

October 17, 2016

Partnership with Bio-Rad Laboratories

On October 17, 2016 Globavir Biosciences announced entering a partnership with Bio-Rad Laboratories to licence Globavir's PanGlob Dengue detection technology. There were no financial details of the partnership and licensing agreement between the two companies.

Edits on 3 Jun, 2020
Dawson Sewell
Dawson Sewell edited on 3 Jun, 2020
Edits made to:
Infobox (+2/--1 properties)
Infobox
Company status
Active
Edits on 28 Oct, 2019
Golden AI"IBI-85"
Golden AI edited on 28 Oct, 2019
Edits made to:
Infobox (+1 properties)
Edits on 8 Jul, 2019
Golden AI"Remove default description"
Golden AI edited on 8 Jul, 2019
Edits made to:
Description (-7 characters)
Topic thumbnail

Globavir Biosciences

Company

Edits on 17 Apr, 2019
Golden AI
Golden AI edited on 17 Apr, 2019
Edits made to:
Description (+7 characters)
Topic thumbnail

Globavir Biosciences

Company

Edits on 7 Mar, 2019
Golden AI
Golden AI edited on 7 Mar, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.